Latest Osteology Stories
New research shows that the Wnt receptor Frizzled-9 (Fzd9) promotes bone formation, providing a potential new target for the treatment of osteoporosis.
Postmenopausal women have a new health message to hear.
Technology offers new options for patients undergoing bone grafts for foot, ankle conditions FORT LAUDERDALE, Fla., March 11, 2011 /PRNewswire/ -- When patients need a bone graft for a foot or ankle surgery, bone often is taken from another part of their body.
The same medicines used to treat angina and chronic heart failure, may also help treat osteoporosis.
Women who take commonly prescribed drugs for osteoporosis known as bisphosphonates for five years or more may be at higher risk of certain kinds of fractures of their thigh bone.
Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft (bone in the leg that extends from the hip to the knee) or subtrochanteric (fractures in the bone just below the hip joint), compared to women with less usage.
Preliminary research indicates that use of nitroglycerin ointment among postmenopausal women for 2 years was associated with a modest increase in bone mineral density and decrease in bone resorption (loss).
Researchers have discovered an unexpected connection between a hormone produced in bone and male fertility.
SAN DIEGO, Feb. 18, 2011 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal care, today announced it has received FDA clearance for the TM-S Trabecular Metal(TM) Cervical Interbody Fusion Device.
ST. LOUIS, Feb. 10, 2011 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held orthobiologics company, announced today that Mitchell Seyedin, Ph.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.